Hemcheck Sweden AB (publ) extended the agreement with Laboratory Medicine within Region Skåne, Sweden. The extension involves minor revenues for Hemcheck and is related to the same project as previously communicated where Hemcheck's v-Test with equipment configured for diagnostic use is used.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.132 SEK | +10.00% | -0.75% | -44.54% |
1st Jan change | Capi. | |
---|---|---|
-44.54% | 3.68M | |
-6.76% | 11.98B | |
-5.68% | 8B | |
+8.91% | 5.85B | |
+28.87% | 5.54B | |
-15.84% | 3.84B | |
+10.70% | 2.66B | |
-60.92% | 2.62B | |
-6.99% | 2.33B | |
+15.67% | 2B |
- Stock Market
- Equities
- BIOVIT Stock
- News Bio Vitos Pharma AB
- Hemcheck Sweden AB Extends Agreement Regarding Previously Communicated Project with Region Skåne